Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data. To view the full list of topics, click here.
Kate Taylor
PSI Conference Chair
For more information on the conference, please click here.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed.
This year's Annual General Meeting will focus on how PSI has navigated the challenges of the past year and adapted to the new online world, as well as how we plan to embrace a new Board structure and new opportunities as we move forward.
Our next journal club features two papers on the topic of “The Use of External Controls in Clinical Trials”. Please join us to hear Chris Harbron (Roche) and Margaret Gamalo (Pfizer) present their recent work. The webinar will be chaired by Nigel Stallard (Warwick University).
We’re now searching at all levels for Biostatisticians and Statistical Programmers to join our International BARDS Health Technology Assessment team at our London and Zurich hubs.
The Associate Director of Biostatistics is the key client interface for all statistical issues and discussions.
In this role you will consult in the design of complex and innovative studies and clinical trial programs as well as Leading DMC/DSMB processes.
This is an excellent opportunity for someone that loves working directly with clients, contributing as a high-level project lead and key contributor.
As a seasoned Biostatistician, will work primarily on Immunology: GI and Dermatology trials with a focus on Late Phase studies. Some PK Analysis experience highly desired.
As a seasoned Biostatistician, will work primarily in late phase oncology.
As an experienced pharmaceutical statistician, you will support Cytel and a client of our Functional Service Provider (FSP) division.
As a Sr Bios, you will function independently as Lead Statistician on projects and support/project statistician on others.
As a Sr Mgr, Biostatistics you will manage a team of Statisticians and Programmers within the FSP department, as well as managing project work.
As a Senior or Principal Biotatistician, you will hold a combined project leadership and hands-on technical statistics role, working across a range of phases and therapeutic areas.
You will participate in the development of study protocols including participation in study design discussions and sample size calculations, and review CRFs and data review guidelines.
As a Senior or Principal Statistician, you will hold a combined project leadership and hands-on technical statistics role., working across a range of phases and therapeutic areas.
We are looking for passionate and motivated statisticians to work within our Services team to deliver high quality, innovative, analytical services within a clinical setting as our KerusCloud platform moves into the next phase.
Would you like to join a dynamic, growing firm where you can really make an impact, not just on the company but to accelerate drug development and ultimately benefit patients?
Have you experience in the application of statistics in the pharmaceutical, healthcare or life science sectors? Do you want to be at the forefront of statistical innovations, leading the way on clinical trial design and analysis?
As a Statistics Manager, you will hold a combined line management, project leadership and technical statistical role, working across a range of phases and therapeutic areas.
